Correlation Between Microsoft and NewAmsterdam Pharma

Can any of the company-specific risk be diversified away by investing in both Microsoft and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Microsoft and NewAmsterdam Pharma, you can compare the effects of market volatilities on Microsoft and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and NewAmsterdam Pharma.

Diversification Opportunities for Microsoft and NewAmsterdam Pharma

-0.09

Correlation Coefficient

Microsoft  NewAmsterdam Pharma

Good diversification

The 3 months correlation between Microsoft and NewAmsterdam is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of Microsoft i.e., Microsoft and NewAmsterdam Pharma go up and down completely randomly.

Pair Corralation between Microsoft and NewAmsterdam Pharma

Given the investment horizon of 90 days Microsoft is expected to generate 9.69 times less return on investment than NewAmsterdam Pharma. But when comparing it to its historical volatility, Microsoft is 5.09 times less risky than NewAmsterdam Pharma. It trades about 0.05 of its potential returns per unit of risk. NewAmsterdam Pharma is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  700.00  in NewAmsterdam Pharma on September 2, 2024 and sell it today you would earn a total of  206.00  from holding NewAmsterdam Pharma or generate 29.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Microsoft  vs.  NewAmsterdam Pharma

Microsoft

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Microsoft are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, Microsoft is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

NewAmsterdam Pharma

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, NewAmsterdam Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Microsoft and NewAmsterdam Pharma

The main advantage of trading using opposite Microsoft and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.

The idea behind Microsoft and NewAmsterdam Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.